Why Drug Distributors Are Buying Cancer Specialists

Drug middlemen are duking it out to buy their customers. Most Americans pick up their prescription drugs at the local pharmacy, but many pricey medications are bought directly by medical providers. Think, for example, of a chemotherapy infusion delivered at a doctor’s office. The intermediaries selling drugs to those doctors run a pretty good business. Now, the big three U.S. drug wholesalers — McKesson, Cencora, and Cardinal Health — are taking control of the doctors, too, to lock them in as customers. The trend isn’t exactly new. Back in 2010, McKesson bought US Oncology for $2.16 billion. But what was once a side hustle has now expanded into an all-out turf war, with all three distributors getting in on the action, driving up the prices of their targets.

Read the full article: Why Drug Distributors Are Buying Cancer Specialists //

Source: https://www.wsj.com/health/pharma/why-drug-distributors-are-buying-cancer-specialists-0ad12c83

Scroll to Top